OClawVPS.com
UroMems
Edit

UroMems

http://www.uromems.com/
Last activity: 26.06.2024
Active
Categories: ActiveBioTechDevelopmentHardwareLifeMedTechProduct
UroMems is a biotechnology company based out of LES REFLETS DU DRAC 32 RUE GUSTAVE EIFFEL, GRENOBLE, France.
Followers
2.07K
Mentions
7
Location: France, Auvergne-Rhone-Alpes, Grenoble
Employees: 11-50
Total raised: $91.85M
Founded date: 2011

Investors 3

Funding Rounds 3

DateSeriesAmountInvestors
26.06.2024Series C$47M-
06.04.2021Series B$27.28M-
20.05.2020Series B$17.57M-

Mentions in press and media 7

DateTitleDescription
26.06.2024UroMems Raises $47M in Series C FinancingUroMems, a Grenoble, France- and Minneapolis, MN-based-based company developing implantable mechatronics technology, raised $47M in Series C funding. The round was led by Crédit Mutuel Innovation and joined by the European Innovation Counci...
08.04.2021French medical device manufacturer UroMems completes €23M in Series B funding(Photo by Thanakorn.P/ Shutterstock)
06.04.2021UroMems Completes €23 Million Series B FinancingUroMems, announced that it has raised an additional €7 million in a second tranche of its previously announced Series B financing round completed in May 2020.
22.05.2020France's UroMems scores €16M Series BMedical device startup UroMems has raised €16 million in a round led by Hil-Invent. The company is developing an electronic artificial urinary sphincter to treat stress incontinence. The capital will be used to fund clinical trials. Additio...
20.05.2020UroMems Raises €16M in FundingUroMems, a Grenoble, France-based developer and manufacturer of the electronic artificial urinary sphincter (eAUS), raised €16m in a combination of equity and debt financing. The round was led by Hil-Invent GmbH, with co-investor Financière...
20.05.2020French medtech company UroMems raises €16 million Series BUroMems, French developer of medical devices that help with urinary incontinence, has secured €16 million in a Series B round, a combination of equity and debt, led by Hil-Invent with co-investor Financière Arbevel. The Grenoble-based compa...
-UroMems“UroMems ambition is to offer to the patients suffering from severe urinary incontinence a simple and efficient innovative solution. In a particularly demanding economic and regulatory context, the company’s ambition is to improve current s...

Reviews 0

Sign up to leave a review

Sign up Log In